Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This is an Extension study of the MICONOS main randomised placebo-controlled trial
(NCT00905268), and open to those patients completing the main study. The scientific aim of
this extension study is to monitor safety and tolerability of idebenone over two years in
patients with Friedreich's Ataxia.